MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain

Gene Therapy

Volumn 21, Issue 1, 2014, Pages 37-43

  Zeng, L ^a,b   He, X ^b   Wang, Y ^a,b,b   Tang, Y ^b   Zheng, C ^a   Cai, H ^a,b   Liu, J ^a   Fu, Y ^a   Yang, G Y ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

angiogenesis; brain; microRNA; microvessel; neurogenesis

Indexed keywords

ANGIOGENIC FACTOR; LENTIVIRUS VECTOR; MICRORNA 210; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BASAL GANGLION; CAPILLARY DENSITY; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE TRANSFER; GENOTYPE; HEMISPHERE; MALE; MICROVASCULATURE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; SUBVENTRICULAR ZONE;

MUS;

ANIMALS; ASTROCYTES; BRAIN; ENDOTHELIAL CELLS; GENETIC VECTORS; LENTIVIRUS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; NEURONS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891746974     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.55     Document Type: Article

References (44)

1. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851. (Pubitemid 38057729)
2. Yang JP, Liu HJ, Liu XF. VEGF promotes angiogenesis and functional recovery in stroke rats. J Invest Surg 2010; 23: 149-155.
3. Liu Y, Sun L, Huan Y, Zhao H, Deng J. Application of bFGF and BDNF to improve angiogenesis and cardiac function. J Surg Res 2006; 136: 85-91. (Pubitemid 44634553)
4. Zhang L, Hu Y, Sun CY, Li J, Guo T, Huang J et al. Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu. Cancer Sci 2010; 101: 1117-1124.
5. Zhu W, Fan Y, Hao Q, Shen F, Hashimoto T, Yang GY et al. Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 1528-1537.
6. Dempsey RJ, Sailor KA, Bowen KK, Tureyen K, Vemuganti R. Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF. J Neurochem 2003; 87: 586-597. (Pubitemid 37310625)
7. Lu H, Wang Y, He X, Yuan F, Lin X, Xie B et al. Netrin-1 hyperexpression in mouse brain promotes angiogenesis and long-term neurological recovery after transient focal ischemia. Stroke 2012; 43: 838-843.
8. Fan Y, Shen F, Chen Y, Hao Q, Liu W, Su H et al. Overexpression of netrin-1 induces neovascularization in the adult mouse brain. J Cereb Blood Flow Metab 2008; 28: 1543-1551.
9. Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab 2005; 25: 1491-1504. (Pubitemid 41541959)
10. Fiore R, Khudayberdiev S, Saba R, Schratt G. MicroRNA function in the nervous system. Prog Mol Biol Transl Sci 2011; 102: 47-100.
11. Van Wynsberghe PM, Chan SP, Slack FJ, Pasquinelli AE. Analysis of microRNA expression and function. Methods Cell Biol 2011; 106: 219-252.
12. Jain KK. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegener Dis 2007; 4: 287-291. (Pubitemid 47026182)
13. Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005; 132: 4645-4652. (Pubitemid 41685275)
14. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA RNA 2005; 11: 1753-1761. (Pubitemid 41720024)
15. Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 2010; 30: 92-101.
16. Chan SY, Loscalzo J. MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 2010; 9: 6.
17. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 2009; 284: 35134-35143.
18. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008; 283: 15878-15883.
19. Pulkkinen K, Malm T, Turunen M, Koistinaho J, Yla-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 2008; 582: 2397-2401.
20. Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F et al. Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res 2011; 35: 182-191.
21. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010; 122(11 Suppl): S124-S131.
22. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011; 219: 211-217.
23. Zeng L, Liu J, Wang Y, Wang L, Weng S, Tang Y et al. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 2011; 3: 1265-1272.
24. Matrai J, Chuah MK, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010; 18: 477-490.
25. Bokhoven M, Stephen SL, Knight S, Gevers EF, Robinson IC, Takeuchi Y et al. Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol 2009; 83: 283-294.
26. Manilla P, Rebello T, Afable C, Lu X, Slepushkin V, Humeau LM et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005; 16: 17-25. (Pubitemid 40250328)
27. Zhao H, Pestina TI, Nasimuzzaman M, Mehta P, Hargrove PW, Persons DA. Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene. Blood 2009; 113: 5747-5756.
28. Font MA, Arboix A, Angiogenesis Krupinski J. neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev 2010; 6: 238-244.
29. Liu XS, Zhang ZG, Zhang RL, Gregg S, Morris DC, Wang Y et al. Stroke induces gene profile changes associated with neurogenesis and angiogenesis in adult subventricular zone progenitor cells. J Cereb Blood Flow Metab 2007; 27: 564-574.
30. Hayashi T, Deguchi K, Nagotani S, Zhang H, Sehara Y, Tsuchiya A et al. Cerebral ischemia and angiogenesis. Curr Neurovasc Res 2006; 3: 119-129. (Pubitemid 43764788)
31. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J. Can angiogenesis be exploited to improve stroke outcome Mechanisms and therapeutic potential. Clin Sci (Lond) 2006; 111: 171-183. (Pubitemid 44352189)
32. Madri JA. Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 2009; 60(Suppl 4): 95-104.
33. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006; 26: 13007-13016. (Pubitemid 44954619)
34. Shen F, Fan Y, Su H, Zhu Y, Chen Y, Liu W et al. Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Therapy 2008; 15: 30-39. (Pubitemid 350269430)
35. Wang YQ, Cui HR, Yang SZ, Sun HP, Qiu MH, Feng XY et al. VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochem Int 2009; 55: 629-636.
36. Wiltrout C, Lang B, Yan Y, Dempsey RJ, Vemuganti R. Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem Int 2007; 50: 1028-1041. (Pubitemid 46962820)
37. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc Res 2002; 53: 993-1001. (Pubitemid 34261037)
38. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006; 1: e116.
39. Yang W, Sun T, Cao J, Liu F, Tian Y, Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 2012; 318: 944-954.
40. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009; 10: 273-284.
41. Chen Z, Li Y, Zhang H, Huang P, Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010; 29: 4362-4368.
42. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284: 33161-33168.
43. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt-and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011; 301: H1519-H1530.
44. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR. Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections. Anticancer Res 2011; 31: 4053-4060.